Neural tube defects and congenital hydrocephalus. Why is prevalence important?;Defeitos do tubo neural e hidrocefalia congênita. Por que conhecer suas prevalências?

Jornal de Pediatria

Volumn 79, Issue 2, 2003, Pages 105-106

  Grillo, Eugênio ^a   Melo da Silva, Ronaldo José ^a  

^a HOSPITAL INFANTIL JOANA DE GUSMÃO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

CONGENITAL HYDROCEPHALUS; EDITORIAL; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; LAW; MATERNAL CARE; NEURAL TUBE DEFECT; POLITICS; PREVALENCE;

EID: 0037572362     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/jped.960     Document Type: Editorial

References (12)

1. Pinar H, Tatevosyants N, Singer DB. Central nervous system malformations in a perinatal/neonatal autopsy series. Pediatr Dev Pathol 1998;1:42-8.
2. Iqbal MM. Prevention of neural tube defects by periconceptional use of folic acid. Pediatr Rev 2000;21:58-66.
3. Aguiar MJB, Campos AS, Aguiar RALP, Lana AMA, Magalhães RL, Babeto LT. Defeitos de fechamento do tubo neural e fatores associados em recém-nascidos vivos e natimortos. J Pediatr (Rio J) 2003;79:129-34.
4. Cavalcanti DP, Salomão MA. Incidência de hidrocefalia congênita e o papel do diagnóstico pré-natal. J Pediatr (Rio J) 2003;79:135-40.
5. Nazer HJ, Lopez-Camelo J, Castilla E. ECLAMC: Estudio de 30 años de vigilancia epidemiológica de defectos de tubo neural en Chile y en Latinoamérica. Rev Med Chile 2001;129:531-9.
6. Dolk H, De Wals P, Gillerot Y, Lechat MF, Ayme S, Cornel M, et al. Heterogeneity of neural tube defects in Europe: the significance of site of defect and presence of other major anomalies in relation to geographic differences in prevalence. Teratology 1991;44:547-59.
7. Stevenson RE, Allen HP, Pai GS, Best R, Seaver LH, Dean J, et al. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics 2000;106:677-83.
8. Ogata AJN, Camano L, Brunoni D. Perinatal factors associated with neural tube defects (anencephaly, spina bifida and encephalocele). Rev Paul Med 1992;147-51.
9. American Academy of Pediatrics. Committee on Genetics. Folic acid for the prevention of neural tube defects. Pediatrics 1999;104:325-7.
10. Brent RL, Oakley GP, Mattison DR. The unnecessary epidemic of folic acid-preventable spina bifida and anencephaly. Pediatrics 2000;106:825-7.
11. Centers for Disease Control and Prevention. Neural tube defect surveillance and folic acid intervention - Texas-Mexico border 1993-1998. MMWR Morb Mortal Wkly Rep 2000;49:1-4.
12. Agência Nacional de Vigilância Sanitária. Consulta Pública n.° 51, de 10 de junho de 2002. Diário Oficial de 12/06/2002. Disponível em: URL: http://www.anvisa.gov.br/consulta/2002/51_2002.htm. Acessado 24 de março de 2003.